In the normal course of the delivery of care, anesthesiologists encounter many patients who
are receiving drugs that affect platelet function as a fundamental part of primary and …

Dual antiplatelet therapy with aspirin and clopidogrel is routinely indicated in patients with
acute coronary syndromes and following percutaneous coronary intervention to reduce the …

Objectives: The aim of this study was to compare outcomes in older individuals receiving
drug-eluting stents (DES) and bare-metal stents (BMS). Background: Comparative …

It remains unclear whether dual antiplatelet therapy> 12 months might carry a better
prognosis after percutaneous coronary intervention (PCI) with drug-eluting stents (DESs). To …

Drug‐eluting stents (DES) have several advantages over bare‐metal stents (BMS), including
significantly lower target vessel revascularization. However, DES is associated with a higher …

Morbidity and mortality for cardiovascular disease are likely to be lower in patients with
hemophilia than in the general male population. However, their clinical impact is increasing …

Aims The benefit of extending clopidogrel treatment beyond the 12-month period
recommended in current guidelines after myocardial infarction (MI) is debated. We analysed …

Cardiovascular medicine has evolved over the last few decades, with the advent of
percutaneous interventional treatments. In particular, balloon angioplasty and …

Background: The optimal duration of dual antiplatelet therapy remains controversial.
Methods and Results: Between December 2006 and March 2008, 823 patients were …

Caring for patients with coronary stents in the perioperative period requires input from a
team consisting of anesthesiologists, surgeons and cardiologists. The management of the …